Cargando…
Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features
BACKGROUND: Owing to its low incidence, there is insufficient clinical awareness and diagnostic experience with primary hepatic malignant vascular tumors (PHMVTs). The aim of our study was to investigate the imaging and clinicopathological features of patients with PHMVTs and analyze the clinicopath...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427980/ https://www.ncbi.nlm.nih.gov/pubmed/32795351 http://dx.doi.org/10.1186/s40644-020-00336-9 |
_version_ | 1783570988447825920 |
---|---|
author | Zhou, Yue Hou, Ping Wang, Feng Li, Bingjie Gao, Jianbo |
author_facet | Zhou, Yue Hou, Ping Wang, Feng Li, Bingjie Gao, Jianbo |
author_sort | Zhou, Yue |
collection | PubMed |
description | BACKGROUND: Owing to its low incidence, there is insufficient clinical awareness and diagnostic experience with primary hepatic malignant vascular tumors (PHMVTs). The aim of our study was to investigate the imaging and clinicopathological features of patients with PHMVTs and analyze the clinicopathological correlations. METHODS: We retrospectively analyzed 42 patients who had pathologically confirmed PHMVT during the period from June 2012 to December 2019 and enrolled them in our study. The computed tomography (CT) and magnetic resonance (MR) images and pathological findings of each patient were recorded. RESULTS: There were more female (29/42) than male patients. The imaging features of primary hepatic angiosarcoma (PHA) (n = 11) included ill-defined margins (11/11, 100%), necrosis (5/11, 45%), calcification (3/11, 27%) and “slow in-slow out” centripetal enhancement (7/11, 64%). Patients with epithelioid hemangioendothelioma (EHE) (n = 15) presented with ill-defined margins (15/15, 100%), necrosis (6/15, 40%), calcification (2/15, 13%), “fast in-slow out” centripetal enhancement (10/15, 67%), halo sign (15/15, 100%), pseudocapsule sign (4/15, 27%), lollipop sign (2/15, 13%) and capsule retraction sign (2/15, 13%). Patients with malignant hemangiopericytoma (MHP) (n = 3) showed ill-defined margins (3/3, 100%), necrosis (3/3, 100%) and “fast in-slow out” progressive enhancement (3/3, 100%). Infantile hemangioendotheliomas (IHEs) (n = 13) were defined by ill-defined margins (7/13, 54%), necrosis (8/13, 62%), calcification (5/13, 38%) and “fast in-slow out” centripetal enhancement (13/13, 100%). Immunohistochemistry showed strong positive expression of CD31, CD34, ERG, FaVIII and FLI-1. Patients with IHE (96 months) and EHE (88 months) had the longest survival times, followed by those with MHP (23 months), while patients with PHA (15 months) had the shortest survival time. CONCLUSION: On CT and MR images, most PHMVTs were ill-defined, heterogeneous, hypervascular masses with centripetal progressive enhancement and possibly calcification, especially in female patients. The prognosis of patients with PHMVT was associated with the pathological type of the tumor. |
format | Online Article Text |
id | pubmed-7427980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74279802020-08-17 Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features Zhou, Yue Hou, Ping Wang, Feng Li, Bingjie Gao, Jianbo Cancer Imaging Research Article BACKGROUND: Owing to its low incidence, there is insufficient clinical awareness and diagnostic experience with primary hepatic malignant vascular tumors (PHMVTs). The aim of our study was to investigate the imaging and clinicopathological features of patients with PHMVTs and analyze the clinicopathological correlations. METHODS: We retrospectively analyzed 42 patients who had pathologically confirmed PHMVT during the period from June 2012 to December 2019 and enrolled them in our study. The computed tomography (CT) and magnetic resonance (MR) images and pathological findings of each patient were recorded. RESULTS: There were more female (29/42) than male patients. The imaging features of primary hepatic angiosarcoma (PHA) (n = 11) included ill-defined margins (11/11, 100%), necrosis (5/11, 45%), calcification (3/11, 27%) and “slow in-slow out” centripetal enhancement (7/11, 64%). Patients with epithelioid hemangioendothelioma (EHE) (n = 15) presented with ill-defined margins (15/15, 100%), necrosis (6/15, 40%), calcification (2/15, 13%), “fast in-slow out” centripetal enhancement (10/15, 67%), halo sign (15/15, 100%), pseudocapsule sign (4/15, 27%), lollipop sign (2/15, 13%) and capsule retraction sign (2/15, 13%). Patients with malignant hemangiopericytoma (MHP) (n = 3) showed ill-defined margins (3/3, 100%), necrosis (3/3, 100%) and “fast in-slow out” progressive enhancement (3/3, 100%). Infantile hemangioendotheliomas (IHEs) (n = 13) were defined by ill-defined margins (7/13, 54%), necrosis (8/13, 62%), calcification (5/13, 38%) and “fast in-slow out” centripetal enhancement (13/13, 100%). Immunohistochemistry showed strong positive expression of CD31, CD34, ERG, FaVIII and FLI-1. Patients with IHE (96 months) and EHE (88 months) had the longest survival times, followed by those with MHP (23 months), while patients with PHA (15 months) had the shortest survival time. CONCLUSION: On CT and MR images, most PHMVTs were ill-defined, heterogeneous, hypervascular masses with centripetal progressive enhancement and possibly calcification, especially in female patients. The prognosis of patients with PHMVT was associated with the pathological type of the tumor. BioMed Central 2020-08-14 /pmc/articles/PMC7427980/ /pubmed/32795351 http://dx.doi.org/10.1186/s40644-020-00336-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Zhou, Yue Hou, Ping Wang, Feng Li, Bingjie Gao, Jianbo Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
title | Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
title_full | Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
title_fullStr | Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
title_full_unstemmed | Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
title_short | Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
title_sort | primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427980/ https://www.ncbi.nlm.nih.gov/pubmed/32795351 http://dx.doi.org/10.1186/s40644-020-00336-9 |
work_keys_str_mv | AT zhouyue primaryhepaticmalignantvasculartumorsafollowupstudyofimagingcharacteristicsandclinicopathologicalfeatures AT houping primaryhepaticmalignantvasculartumorsafollowupstudyofimagingcharacteristicsandclinicopathologicalfeatures AT wangfeng primaryhepaticmalignantvasculartumorsafollowupstudyofimagingcharacteristicsandclinicopathologicalfeatures AT libingjie primaryhepaticmalignantvasculartumorsafollowupstudyofimagingcharacteristicsandclinicopathologicalfeatures AT gaojianbo primaryhepaticmalignantvasculartumorsafollowupstudyofimagingcharacteristicsandclinicopathologicalfeatures |